Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johny Nicolas

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
The Canadian Journal of Cardiology|February 13, 2022
Prognostic Value of Baseline Inflammation in Diabetic and Nondiabetic Patients Undergoing Percutaneous Coronary InterventionCarlo Andrea Pivato, Davis Jones, Davide Cao, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 28, 2021
Impact of anemia on short-term outcomes after TAVR: A subgroup analysis from the BRAVO-3 randomized trialVictor Razuk, Anton Camaj, Davide Cao, et al.
European Journal of Preventive Cardiology|October 22, 2025
Impact of Remnant Cholesterol on Cardiovascular Outcomes in Non-Myocardial Infarction Patients Undergoing Percutaneous Coronary InterventionNicholas Pitaro, Benjamin Bay, Samantha Sartori, et al.
Journal of Thrombosis and Thrombolysis|August 14, 2025
Timing, indications and transition patterns associated with cangrelor use in patients undergoing PCIAngelo Oliva, Davide Cao, Mark Shneyderman, et al.
Journal of Thrombosis and Thrombolysis|August 13, 2021
Perioperative risk and antiplatelet management in patients undergoing non-cardiac surgery within 1 year of PCIDavide Cao, Matthew A Levin, Samantha Sartori, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 3, 2022
Antithrombotic strategy variability in atrial fibrillation and obstructive coronary disease revascularised with percutaneous coronary intervention: primary results from the AVIATOR 2 international registryJaya Chandrasekhar, Usman Baber, Samantha Sartori, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 10, 2023
Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO-3 randomized trialDaniel Feldman, Davide Cao, Samantha Sartori, et al.
The American Journal of Cardiology|February 20, 2025
Treatment of Additional Vessels During Percutaneous Coronary Intervention for Unprotected Left Main Disease: Insights From a Large Prospective RegistrySean Gilhooley, David Power, Anastasios Roumeliotis, et al.
Journal of Thrombosis and Thrombolysis|August 4, 2021
Performance of the academic research consortium high-bleeding risk criteria in patients undergoing PCI for acute myocardial infarctionJohny Nicolas, Frans Beerkens, Davide Cao, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 7, 2022
Perioperative management of P2Y12 inhibitors in patients undergoing cardiac surgery within 1 year of PCIDavide Cao, Julie A Swain, Samantha Sartori, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
The Canadian Journal of Cardiology|February 13, 2022
Prognostic Value of Baseline Inflammation in Diabetic and Nondiabetic Patients Undergoing Percutaneous Coronary InterventionCarlo Andrea Pivato, Davis Jones, Davide Cao, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 28, 2021
Impact of anemia on short-term outcomes after TAVR: A subgroup analysis from the BRAVO-3 randomized trialVictor Razuk, Anton Camaj, Davide Cao, et al.
European Journal of Preventive Cardiology|October 22, 2025
Impact of Remnant Cholesterol on Cardiovascular Outcomes in Non-Myocardial Infarction Patients Undergoing Percutaneous Coronary InterventionNicholas Pitaro, Benjamin Bay, Samantha Sartori, et al.
Journal of Thrombosis and Thrombolysis|August 14, 2025
Timing, indications and transition patterns associated with cangrelor use in patients undergoing PCIAngelo Oliva, Davide Cao, Mark Shneyderman, et al.
Journal of Thrombosis and Thrombolysis|August 13, 2021
Perioperative risk and antiplatelet management in patients undergoing non-cardiac surgery within 1 year of PCIDavide Cao, Matthew A Levin, Samantha Sartori, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 3, 2022
Antithrombotic strategy variability in atrial fibrillation and obstructive coronary disease revascularised with percutaneous coronary intervention: primary results from the AVIATOR 2 international registryJaya Chandrasekhar, Usman Baber, Samantha Sartori, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 10, 2023
Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO-3 randomized trialDaniel Feldman, Davide Cao, Samantha Sartori, et al.
The American Journal of Cardiology|February 20, 2025
Treatment of Additional Vessels During Percutaneous Coronary Intervention for Unprotected Left Main Disease: Insights From a Large Prospective RegistrySean Gilhooley, David Power, Anastasios Roumeliotis, et al.
Journal of Thrombosis and Thrombolysis|August 4, 2021
Performance of the academic research consortium high-bleeding risk criteria in patients undergoing PCI for acute myocardial infarctionJohny Nicolas, Frans Beerkens, Davide Cao, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 7, 2022
Perioperative management of P2Y12 inhibitors in patients undergoing cardiac surgery within 1 year of PCIDavide Cao, Julie A Swain, Samantha Sartori, et al.
Pageof 8